Download PDF
Horm Metab Res 2019; 51(10): 661-670
DOI: 10.1055/a-0969-1872
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

THADA_rs13429458 Minor Allele Increases the Risk of Polycystic Ovary Syndrome in Asian, but Not in Caucasian Women: A Systematic Review and Meta-Analysis

Sunmin Park
1   Department of Food and Nutrition, College of Life and Health Sciences, Hoseo University, Chungnam, Korea
,
Meiling Liu
1   Department of Food and Nutrition, College of Life and Health Sciences, Hoseo University, Chungnam, Korea
,
Ting Zhang
1   Department of Food and Nutrition, College of Life and Health Sciences, Hoseo University, Chungnam, Korea
› Author Affiliations
Further Information

Publication History

received 26 March 2019

accepted 01 July 2019

Publication Date:
05 September 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Polycystic ovary syndrome (PCOS) is a highly prevalent disease in young women that also features increased insulin resistance. Genetic factors have a strong relationship with the etiology of PCOS. We assessed whether carrying THADA rs13429458 is associated with the development of PCOS by meta-analysis and whether the association is influenced by ethnicity. Articles were searched using PubMed, EMBASE, Cochrane Library, Korean scientific database, and Chinese and Indian medical databases to identify all eligible studies for evaluating the association of THADA rs13429458 and PCOS risk. The association was assessed in five genetic random effects models including the allelic (AG), recessive (RG), dominant (DG), homozygous (HMG), and heterozygous (HTG) genetic models. Subgroup analyses stratified by ethnicity (Asians and non-Asians) were assessed. Nine articles were selected and 1 association analysis of Korea PCOS study met Hardy–Weinberg equilibrium criteria. A set of 38 224 PCOS women and 120 173 healthy women were included. The AG and RG showed heterogeneity in the overall and Asian subjects, but the other genetic model did not exhibit heterogeneity in all subjects. AG, RG, DG, and HMG, but not HTG, exhibited publication bias in total subjects but there was no publication bias in all genetic models among Asians and non-Asians. The overall effect of THADA_rs13429458 on PCOS risk showed significant positive associations in pooling 10 studies. In sub-group analysis only Asians, but not non-Asians, had a positive association (AG: OR=1.24, p=0.001; RG: OR=1.32, p=0.002; DG: OR, 1.70, p<0.00001; HMG: OR, 1.71, p=0.002; HTG: OR=1.34, p=0,006). In conclusions, young Asian women with the minor allele (C) for THADA rs13429458 were at increased risk of PCOS.

Key words

polycystic ovary syndrome - THADA - rs13429458 - Asians - Caucasians

Supplementary Material

 

  • References

  • 1 Lizneva D, Suturina L, Walker W. et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106: 6-15
    CrossrefPubMedGoogle Scholar
  • 2 Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: Whatʼs new?. Adv Clin Exp Med 2017; 26: 359-367
    CrossrefPubMedGoogle Scholar
  • 3 Crespo RP, Bachega T, Mendonca BB. et al. An update of genetic basis of PCOS pathogenesis. Arch Endocrinol Metab 2018; 62: 352-361
    CrossrefPubMedGoogle Scholar
  • 4 Kakoly NS, Khomami MB, Joham AE. et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: A systematic review and meta-regression. Hum Reprod Update 2018; 24: 455-467
    CrossrefPubMedGoogle Scholar
  • 5 Bjonnes AC, Saxena R, Welt CK. Relationship between polycystic ovary syndrome and ancestry in European Americans. Fertil Steril 2016; 106: 1772-1777
    CrossrefPubMedGoogle Scholar
  • 6 Ha L, Shi Y, Zhao J. et al. Association study between polycystic ovarian syndrome and the susceptibility genes polymorphisms in Hui Chinese Women. PloS One 2015; 10: e0126505-e0126505
    CrossrefPubMedGoogle Scholar
  • 7 March WA, Moore VM, Willson KJ. et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551
    CrossrefPubMedGoogle Scholar
  • 8 Louwers YV, Stolk L, Uitterlinden AG. et al. Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome. J Clin Endocrinol Metab 2013; 98: E2006-E2012
    CrossrefPubMedGoogle Scholar
  • 9 Li T, Zhao H, Zhao X. et al. Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome. J Med Genet 2012; 49: 254-257
    CrossrefPubMedGoogle Scholar
  • 10 Wang Z, Li T, Xing X. et al. Replication study of RAD54B and GREB1 polymorphisms and risk of PCOS in Han Chinese. Reprod Biomed Online 2013; 27: 316-321
    CrossrefPubMedGoogle Scholar
  • 11 Hayes MG, Urbanek M, Ehrmann DA. et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 2015; 6: 7502
    CrossrefPubMedGoogle Scholar
  • 12 Day FR, Hinds DA, Tung JY. et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun 2015; 6: 8464
    CrossrefPubMedGoogle Scholar
  • 13 Kowalczyk K, Franik G, Kowalczyk D. et al. Thyroid disorders in polycystic ovary syndrome. Eur Rev Med Pharmacol Sci 2017; 21: 346-360
    PubMedGoogle Scholar
  • 14 Moraru A, Cakan-Akdogan G, Strassburger K. et al. THADA regulates the organismal balance between energy storage and heat production. Dev Cell 2017; 41: 72-81.e76
    CrossrefPubMedGoogle Scholar
  • 15 Christodoulou MI, Avgeris M, Kokkinopoulou I. et al. Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk. Sci Rep 2019; 9: 1512
    CrossrefPubMedGoogle Scholar
  • 16 Brower MA, Jones MR, Rotter JI. et al. Further investigation in Europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab 2015; 100: E182-E186
    CrossrefPubMedGoogle Scholar
  • 17 Goodarzi MO, Jones MR, Li X. et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet 2012; 49: 90-95
    CrossrefPubMedGoogle Scholar
  • 18 Little J, Higgins JP, Ioannidis JP. et al. STrengthening the REporting of Genetic Association Studies (STREGA)–an extension of the STROBE statement. Genet Epidemiol 2009; 33: 581-598
    CrossrefPubMedGoogle Scholar
  • 19 Higgins JPT, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. BMJ: Brit Med J 2003; 327: 557
    PubMedGoogle Scholar
  • 20 Chen Z-J, Zhao H, He L. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16. 3, 2p21 and 9q33. 3. Nat Genet 2011; 43: 55
    CrossrefPubMedGoogle Scholar
  • 21 Bao S, Ren Y-C, Chen Z-S. et al. THADA gene variants and polycystic ovary syndrome in a Hainan Chinese population. Int J Clin Exp Pathol 2016; 9: 11883-11889
    PubMedGoogle Scholar
  • 22 Huang Y-H, Ding J-B, Li X. et al. Association of LHCGR gene, THADA gene, DENND1A gene single nucleotide polymorphism with polycystic ovary syndrome in Xinjiang. J Xinjiang Med Univ 2016; 39: 997-1003
    PubMedGoogle Scholar
  • 23 Li X, Huang Y-H, Tian H-Q. et al. Association study between polycystic ovary syndrome and THADA gene polymorphisms in xinjiang uygur women. Reprod Develop Med 2017; 1: 80
    PubMedGoogle Scholar
  • 24 Cui L-L. Analysis of phenotypes and their correlation with genotypes of susceptibility genes in PCOS. Shan Dong University 2013; 20-22
    PubMedGoogle Scholar
  • 25 Lerchbaum E, Trummer O, Giuliani A. et al. Susceptibility loci for polycystic ovary syndrome on chromosome 2p16. 3, 2p21, and 9q33. 3 in a cohort of Caucasian women. Horm Metab Res 2011; 43: 743-747
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Eriksen MB, Brusgaard K, Andersen M. et al. Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis. Eur J Obstet Gynecol Reprod Biol 2012; 163: 39-42
    CrossrefPubMedGoogle Scholar
  • 27 Goodarzi MO, Jones MR, Li X. et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet 2012; 49: 90-95
    CrossrefPubMedGoogle Scholar
  • 28 Welt CK, Styrkarsdottir U, Ehrmann DA. et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab 2012; 97: E1342-E1347
    CrossrefPubMedGoogle Scholar
  • 29 Gilbert EW, Tay CT, Hiam DS. et al. Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews. Clin Endocrinol (Oxf) 2018; 89: 683-699
    CrossrefPubMedGoogle Scholar
  • 30 Lim SS, Kakoly NS, Tan JWJ. et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev 2019; 20: 339-352
    CrossrefPubMedGoogle Scholar
  • 31 Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev 2016; 37: 467-520
    CrossrefPubMedGoogle Scholar
  • 32 Azziz R, Carmina E, Chen Z. et al. Polycystic ovary syndrome. Nat Rev Dis Primers 2016; 2: 16057
    CrossrefPubMedGoogle Scholar
  • 33 Chatterjee N, Perrimon N. Thermogenesis by THADA. Dev Cell 2017; 41: 1-2
    CrossrefPubMedGoogle Scholar
  • 34 Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism 2019; 92: 108-120
    CrossrefPubMedGoogle Scholar
  • 35 Shi Y, Zhao H, Shi Y. et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 2012; 44: 1020-1025
    CrossrefPubMedGoogle Scholar
  • 36 Voight BF, Scott LJ, Steinthorsdottir V. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42: 579-589
    CrossrefPubMedGoogle Scholar
  • 37 Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What's new ?. Adv Clin Exp Med 2017; 26: 359-367
    CrossrefPubMedGoogle Scholar
  • 38 Jin P, Xie Y. Treatment strategies for women with polycystic ovary syndrome. Gynecol Endocrinol 2018; 34: 272-277
    CrossrefPubMedGoogle Scholar
  • 39 Chan JC, Malik V, Jia W. et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140
    CrossrefPubMedGoogle Scholar